These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17379634)

  • 1. Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.
    Tan JH; Al Abed A; Brock JA
    J Physiol; 2007 Jun; 581(Pt 2):757-65. PubMed ID: 17379634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
    Wellman GC; Barrett-Jolley R; Köppel H; Everitt D; Quayle JM
    Br J Pharmacol; 1999 Oct; 128(4):909-16. PubMed ID: 10556925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two mechanisms underlie the slow noradrenergic depolarization in the rat tail artery in vitro.
    Rummery NM; Brock JA
    Auton Neurosci; 2011 Jan; 159(1-2):45-50. PubMed ID: 20739228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
    Ploug KB; Boni LJ; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
    Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of norepinephrine release by ATP-dependent K(+)-channel activators and inhibitors in guinea-pig and human isolated right atrium.
    Oe K; Sperlágh B; Sántha E; Matkó I; Nagashima H; Foldes FF; Vizi ES
    Cardiovasc Res; 1999 Jul; 43(1):125-34. PubMed ID: 10536697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicorandil on sympathetic neurotransmission in rat caudal artery.
    Tei A; Nejime N; Tada Y; Kagota S; Tanabe Y; Hashimoto M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):619-23. PubMed ID: 20132237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of levcromakalim and pinacidil on the human internal mammary artery.
    Gojkoviíc Bukarica L; Kazić T; Sajić Z; Djukanović B; Panić G; Perić M; Bojić M
    Fundam Clin Pharmacol; 1997; 11(6):550-60. PubMed ID: 9444523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of pinacidil and levcromakalim on the contractions elicited electrically or by noradrenaline in the portal vein of the rabbit.
    Gojković-Bukarica L; Kazić T
    Fundam Clin Pharmacol; 1999; 13(5):527-34. PubMed ID: 10520724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
    Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
    J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    Ohrnberger CE; Khan SA; Meisheri KD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.
    Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U
    Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.
    Glavind-Kristensen M; Matchkov V; Hansen VB; Forman A; Nilsson H; Aalkjaer C
    Br J Pharmacol; 2004 Dec; 143(7):872-80. PubMed ID: 15504751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
    J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
    Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic control of arterial membrane potential by ATP-sensitive K(+)-channels.
    Goto K; Fujii K; Abe I; Fujishima M
    Hypertension; 2000 Jan; 35(1 Pt 2):379-84. PubMed ID: 10642328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227).
    Noack T; Edwards G; Deitmer P; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):945-55. PubMed ID: 1467843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.